Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.
about
Understanding the role of B cells in atherosclerosis: potential clinical implicationsThe influence of innate and adaptive immune responses on atherosclerosisThe role of T and B cells in human atherosclerosis and atherothrombosisInflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm researchB cells and atherosclerosis.Artery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE-/- Mice.B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.B2 cells suppress experimental abdominal aortic aneurysms.B cell subsets in atherosclerosis.B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.B cells and humoral immunity in atherosclerosisCutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE(-/-) mouse model of atherosclerosis.BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) miceB-1a lymphocytes attenuate insulin resistanceThe mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosisPreparation of Single Cell Suspensions from Mouse AortaImpact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques.A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting.Adaptive immunity in atherogenesis: new insights and therapeutic approaches.Immune effector mechanisms implicated in atherosclerosis: from mice to humans.TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.Bone marrow-specific knock-in of a non-activatable Ikkα kinase mutant influences haematopoiesis but not atherosclerosis in Apoe-deficient mice.Accelerated atherosclerosis in SLE: mechanisms and prevention approaches.Inflammation and immune system interactions in atherosclerosis.Vaccines against atherosclerosis.Molecular biology of atherosclerosis.B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.Multiple potential roles for B cells in atherosclerosis.Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.Macrophages and immune cells in atherosclerosis: recent advances and novel concepts.BAFF receptor and TACI in B-1b cell maintenance and antibacterial responses.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.Rhein inhibits the expression of vascular cell adhesion molecule 1 in human umbilical vein endothelial cells with or without lipopolysaccharide stimulation.Blockade of B-cell-activating factor signaling enhances hepatic steatosis induced by a high-fat diet and improves insulin sensitivity.The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease.Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression.Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia.
P2860
Q26991813-AC78F6FC-D3BB-4B19-A0CE-C703992F4125Q27000370-DE1152E1-4402-497E-9F45-23C19F862710Q27000791-CAA1F6D9-DB6C-4DD0-8514-3F20BB341FB4Q28084855-825FEF2C-A54A-43C9-B261-F014470C9E3DQ30252928-025EB1F6-D9C4-45D8-9AE4-0C38412968A3Q30276940-71E8E752-3248-494B-B17D-A0810A3E61C8Q30279171-784A50BF-D2B5-4116-BB85-B153431254C4Q30370021-A2C33235-3291-4ACD-A75A-C3EE8C302060Q30423324-859A3AC3-CE34-42F6-B01D-B4E2AD511C5CQ33704093-BB867770-D429-4650-A949-08BAF4B0CC5DQ33789638-52A44828-84E1-4262-9A2C-5080969FF245Q34130293-495EF155-BE61-4EEC-8FD3-A444B9ED58E3Q34656412-8457E180-FDE0-4148-B6A0-B5F840A15DEDQ35004327-5EE9BD2D-D53C-4D05-98E1-95D4B236AEA5Q35104236-B05AA64E-ED66-4BC0-B2C4-CA200DEFEDEBQ36059694-7F76CDA5-C509-4305-8457-27A03E3FDA5EQ36184299-FB92D303-DD57-4EDF-B84D-5F63E5AA86AAQ36261019-F8938BFE-CDCC-4A58-BE6C-911F1BC1D3AAQ36497196-9CBC17EB-EFCF-45F5-A88F-261E3B402872Q37150605-2D484863-2FF2-4392-A969-A685070B17F2Q37494039-DEEB7BEE-310F-479D-94AE-83C45735A052Q37548680-DF7995E3-B755-4E52-AF68-550119ED269AQ37658524-C6326039-E5B1-41D0-9C9C-834EC9FF6D63Q38083555-E7EC4649-89CD-4A15-8CD2-90067365D4BDQ38089941-18326904-27B1-48DB-B6C7-1BD9C4E34DDFQ38125279-355A0ACA-FF77-4949-AFB6-15296EFA2FF4Q38152732-D2E477ED-7BFC-4C51-871C-1505B89D5D53Q38210609-0C2987C0-895F-4C2D-A48B-107CCB735929Q38265002-C8FFC9B5-0344-416C-920F-D62283E4EB97Q38346930-DFF6320B-1765-4BDB-BE8E-4E376A6E21FEQ38406177-C1526989-15BA-4F0E-ADDD-53908BE17F22Q38462573-B9AB5EF4-B567-4899-B91A-17E5D8ED8C05Q38472786-D49D2308-C55C-4C64-9476-86DC8B97E70AQ38774904-5A607F26-5B66-49A7-AE0D-BE99DB253469Q39147048-3C83F3FA-20D7-4915-9B9E-2FDCD2A2D969Q39210681-4CAA1159-C9F9-4348-B07A-960CBCFA2AE6Q41709158-F7D1E490-703C-47C7-AEFA-8990962B0A51Q42373676-CDDDA99B-5261-479F-BADD-7F6BF7F50450Q43109046-34F95C87-4607-4B23-9E23-69E550676457Q46224491-E615B03D-7B97-4144-AB1D-CB9A1738C4A2
P2860
Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@ast
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@en
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@nl
type
label
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@ast
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@en
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@nl
altLabel
Depletion of B2 but Not B1a B ...... iorating Arterial Inflammation
@en
prefLabel
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@ast
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@en
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@nl
P2093
P2860
P1433
P1476
Depletion of B2 but not B1a B ...... orating arterial inflammation.
@en
P2093
Alex Bobik
Ban-Hock Toh
Christopher Tay
Fabeinne MacKay
Hamid Hosseini
Peter Kanellakis
Peter Tipping
Tahlia Gadowski
P2860
P304
P356
10.1371/JOURNAL.PONE.0029371
P407
P50
P577
2012-01-04T00:00:00Z